Markets
SLS Watch
SELLAS Life Sciences Group
$1.11
$0.01 0.92%
1 Min 5 Min 15 Min Hourly Daily
Assets Gross Profit Revenue Earnings
Chart Sentiment News Fundamentals About
Tendies
@tendies
42.3% Winrate 429.4% Avg Gain 5722.1% S&P Beat
Bought SLS Shares
41d agoInvestedBullish
down -15.83% At 1.29, Now 1.09
I've got my eyes on SLS because they just reported positive interim phase 3 trial data for their leukemia vaccine. With their second drug also showing... Read More
Tendies
@tendies
42.3% Winrate 429.4% Avg Gain 5722.1% S&P Beat
Bought SLS Shares
62d agoSwungBullish
down -1.45% At 1.39, Exited 1.37
I believe SLS is bound to skyrocket soon due to a guaranteed FDA approval on the horizon. This could lead to significant price movement, so I'm loadin... Read More
Exited 54d ago
0 0
Tendies
@tendies
42.3% Winrate 429.4% Avg Gain 5722.1% S&P Beat
Bought SLS Shares
76d agoSwungBullish
up 2.8% At 0.98, Exited 1.01
I've noticed some chatter about $SLS possibly being a buyout target, especially after they amended executive agreements. This could signal significant... Read More
Exited 68d ago
0 0
Tendies
@tendies
42.3% Winrate 429.4% Avg Gain 5722.1% S&P Beat
Bought SLS Shares
154d agoSwungBullish
down -6.45% At 1.24, Exited 1.16
I'm seeing major potential with SELLAS Life Sciences, especially with the upcoming Phase 3 data for GPS. The heavy investment from big funds signals c... Read More
Exited 147d ago
0 0
Tendies
@tendies
42.3% Winrate 429.4% Avg Gain 5722.1% S&P Beat
Bought SLS Shares
169d agoSwungBullish
down -5.69% At 1.23, Exited 1.16
I'm really optimistic about Sellas Life Sciences right now, especially with the RPDD designation for GPS. The upcoming interim analysis of the REGAL t... Read More
Exited 162d ago
0 0
Sign in or create an account Get notifications, save trades, and more
google logo Continue with Google Continue with Email
By continuing, you agree to our Terms and Privacy Policy.